Growth Metrics

Fulgent Genetics (FLGT) Total Non-Current Liabilities (2016 - 2026)

Fulgent Genetics' Total Non-Current Liabilities history spans 11 years, with the latest figure at $102.8 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 33.82% to $102.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $102.8 million, a 33.82% increase, with the full-year FY2025 number at $99.2 million, up 9.66% from a year prior.
  • Total Non-Current Liabilities hit $102.8 million in Q1 2026 for Fulgent Genetics, up from $99.2 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for FLGT hit a ceiling of $149.2 million in Q2 2022 and a floor of $74.7 million in Q2 2023.
  • Historically, Total Non-Current Liabilities has averaged $98.9 million across 5 years, with a median of $97.3 million in 2024.
  • Biggest five-year swings in Total Non-Current Liabilities: tumbled 49.96% in 2023 and later surged 33.82% in 2026.
  • Tracing FLGT's Total Non-Current Liabilities over 5 years: stood at $97.9 million in 2022, then dropped by 1.92% to $96.1 million in 2023, then decreased by 5.85% to $90.4 million in 2024, then increased by 9.66% to $99.2 million in 2025, then rose by 3.69% to $102.8 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for FLGT at $102.8 million in Q1 2026, $99.2 million in Q4 2025, and $91.8 million in Q3 2025.